Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/31891
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Costa, A. R. | por |
dc.contributor.author | Rodrigues, E. | por |
dc.contributor.author | Henriques, Mariana | por |
dc.contributor.author | Oliveira, Rosário | por |
dc.contributor.author | Azeredo, Joana | por |
dc.date.accessioned | 2014-12-11T18:43:56Z | - |
dc.date.available | 2014-12-11T18:43:56Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0738-8551 | por |
dc.identifier.uri | https://hdl.handle.net/1822/31891 | - |
dc.description.abstract | The emergence of the biopharmaceutical industry represented a major revolution for modern medicine, through the development of recombinant therapeutic proteins that brought new hope for many patients with previously untreatable diseases. The ever-growing demand for these therapeutics forces a constant technological evolution to increase product yields while simultaneously reducing costs. However, the process changes made for this purpose may also affect the quality of the product, a factor that was initially overlooked but which is now a major focus of concern. Of the many properties determining product quality, glycosylation is regarded as one of the most important, influencing, for example, the biological activity, serum half-life and immunogenicity of the protein. Consequently, monitoring and control of glycosylation is now critical in biopharmaceutical manufacturing and a requirement of regulatory agencies. A rapid evolution is being observed in this context, concerning the influence of glycosylation in the efficacy of different therapeutic proteins, the impact on glycosylation of a diversity of parameters/processes involved in therapeutic protein production, the analytical methodologies employed for glycosylation monitoring and control, as well as strategies that are being explored to use this property to improve therapeutic protein efficacy (glycoengineering). The present work reviews the main findings on these subjects, providing an up-to-date source of information to support further studies. | por |
dc.description.sponsorship | This work was financially supported by the Portuguese Foundation for Science and Technology (FCT), with grants SFRH/BD/46660/2008 for Ana Rita Costa and SFRH/BD/46661/2008 for Maria Elisa Rodrigues. | por |
dc.language.iso | eng | por |
dc.publisher | Informa Healthcare | por |
dc.rights | restrictedAccess | por |
dc.subject | Analytical methodologies | por |
dc.subject | Culture parameters | por |
dc.subject | Expression system | por |
dc.subject | Glycoengineering | por |
dc.subject | Mammalian cells | por |
dc.subject | Process development | por |
dc.title | Glycosylation: impact, control and improvement during therapeutic protein production | por |
dc.type | article | - |
dc.peerreviewed | yes | por |
dc.relation.publisherversion | http://informahealthcare.com/journal/bty | por |
dc.comments | CEB14760 | por |
sdum.publicationstatus | published | por |
oaire.citationStartPage | 281 | por |
oaire.citationEndPage | 299 | por |
oaire.citationIssue | 4 | por |
oaire.citationConferencePlace | United Kingdom | - |
oaire.citationTitle | Critical Reviews in Biotechnology | por |
oaire.citationVolume | 34 | por |
dc.date.updated | 2014-12-01T11:07:23Z | - |
dc.identifier.eissn | 1549-7801 | - |
dc.identifier.doi | 10.3109/07388551.2013.793649 | por |
dc.identifier.pmid | 23919242 | por |
dc.subject.wos | Science & Technology | por |
sdum.journal | Critical Reviews in Biotechnology | por |
Aparece nas coleções: | CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
document_14760_1.pdf Acesso restrito! | 622,17 kB | Adobe PDF | Ver/Abrir |